OMNES
Omnes Capital S.A.S. is a private equity and venture capital firm based in Paris, France, with additional offices in Brussels and Zurich. Founded in 2000, the firm specializes in a range of investment strategies, including direct investments in seed and growth-stage companies as well as fund of funds investments. Omnes Capital has a strong focus on sectors such as information technology, life sciences, and renewable energy, and has invested over €500 million in various innovative SMEs. With a total of €3.4 billion in assets under management, the firm has completed 65 business sales, including 14 IPOs, showcasing its expertise in financing companies through buyouts, growth capital, and private debt. Omnes Capital aims to support small and mid-cap enterprises, taking minority stakes and often seeking board representation in its portfolio companies. The firm is recognized for its strategic investments in both established markets and emerging sectors, demonstrating a commitment to fostering growth across various industries.
Wizaplace is a software as a service platform based in Lyon, France, that specializes in the creation and management of online marketplaces. Established in 2012 and officially launched in 2015, the platform supports various marketplace models, including B2C, B2B, and C2C, as well as tailored service marketplaces. It features an integrated environment with approximately 70 modules that facilitate the development of diverse e-commerce solutions, e-services, crowdfunding initiatives, and collaborative platforms. The company was co-founded and is run by Eric and Cécile Alessandri, and as of January 2017, it had a team of around 20 employees.
Tilkee SARL operates an online platform designed to enhance the submission and tracking of business proposals across various sectors. Founded in 2012 and based in Lyon, France, the platform allows professionals to create and host customized commercial proposals easily. Users can upload sales documents, generate branded online proposals, and share unique access links with potential clients. Tilkee's technology provides real-time notifications about prospect engagement, detailing which documents were read, the duration of engagement, and specific areas of interest. This functionality helps sales teams optimize their follow-up strategies and improve their closing rates.
ForCity, based in Lyon, France, is a developer of decision support services and 4D urban simulation software aimed at policy-makers and business decision-makers. Founded in 2014, the company offers a collaborative platform that allows users to simulate projects in a digital environment, where geographical features and infrastructure are modeled to assess their interactions. Utilizing complex systems modeling and a user-friendly 2D-3D visualization engine, ForCity's applications enable real-time simulations that help users anticipate the impacts of their investments and facilitate collaboration among project stakeholders. The company's services are utilized by clients worldwide, enhancing planning and decision-making processes in urban development.
Camerus SAS specializes in the rental and leasing of furniture targeted at decorators, trade fairs, congress organizers, and event agencies. Founded in 1992 and headquartered in Gonesse, France, the company provides a wide range of furniture options including chairs, armchairs, lounges, tables, desks, display units, and multimedia systems. Its offerings cater to various large-scale events, such as trade shows and congresses, with additional products like floral-décor systems and accessories. Camerus also has locations in major French cities, including Paris, Lyon, and Toulouse.
Poxel S.A. is a biopharmaceutical company based in Lyon, France, focused on developing innovative treatments for metabolic diseases, primarily type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009 as a spin-off from Merck Serono, Poxel is advancing its lead product, Imeglimin, through Phase III clinical trials; this oral anti-diabetic candidate targets organ functions affected by diabetes, such as the pancreas, liver, and muscles. The company is also developing PXL770, currently in Phase IIa trials, which activates the adenosine monophosphate-activated protein kinase (AMPK) to manage energy metabolism, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I trials for NASH. Additionally, Poxel has a licensing agreement with Enyo Pharma for the development of PXL007, an FXR agonist in Phase I studies for hepatitis B and NASH. The company’s pipeline reflects its commitment to addressing critical targets in cellular energy regulation, which are vital for treating metabolic disorders.
Poxel S.A. is a biopharmaceutical company based in Lyon, France, focused on developing innovative treatments for metabolic diseases, primarily type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009 as a spin-off from Merck Serono, Poxel is advancing its lead product, Imeglimin, through Phase III clinical trials; this oral anti-diabetic candidate targets organ functions affected by diabetes, such as the pancreas, liver, and muscles. The company is also developing PXL770, currently in Phase IIa trials, which activates the adenosine monophosphate-activated protein kinase (AMPK) to manage energy metabolism, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I trials for NASH. Additionally, Poxel has a licensing agreement with Enyo Pharma for the development of PXL007, an FXR agonist in Phase I studies for hepatitis B and NASH. The company’s pipeline reflects its commitment to addressing critical targets in cellular energy regulation, which are vital for treating metabolic disorders.
Private Equity Round in 2008
Groupe LEXSI S.A. is a provider of security threat intelligence solutions based in Bagnolet, France, with additional offices in Paris, Lyon, Lille, Tunis, Montreal, and Singapore. Established in 1999, the company operates a Software-as-a-Service (SaaS) platform that includes a range of tools designed to identify, assess, and remediate vulnerabilities within information systems. Key offerings include the Threat Defense Center, real-time endpoint fraud analysis, a USB Malware Cleaner, and MULTIPROXIES for secure IP address management. LEXSI also delivers specialized auditing, consulting, incident response, and training services in IT security to over 400 active clients. The company has been a subsidiary of Orange S.A. since 2016.
Emalec is a building systems maintenance and repair business.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.